Misoprostol With or Without Letrozole in Treatment of Missed Miscarriage

NCT04593108 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 320

Last updated 2020-10-20

No results posted yet for this study

Summary

Aim of study Compare the success rate of misoprostol with versus without letrozole as a pretreatment for medical termination of pregnancy during the first trimester.

Hypothesis:

Letrozole value as a pre-treatment medication for misoprostol in induction of abortion during the first trimester.

Research question:

Will letrozole- misoprostol protocol give better results than misoprostol- alone protocol in induction of abortion during the first trimester?

Conditions

  • Missed Abortion

Interventions

DEVICE

Letrozole misoprostol

Letrozole give pretreatment of abortion by misoprostol

DRUG

Misoprostol, placebo

Give placebo pretreatment of abortion by misoprostol

Sponsors & Collaborators

  • Benha University

    collaborator OTHER
  • Dr.Dalia Mohammed Al Sayed Zaki

    lead OTHER

Principal Investigators

  • Zagazig General hospital, Ministry hospital · Zagazig general hospital

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-01-15
Primary Completion
2020-10-01
Completion
2020-11-15
FDA Drug
Yes

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04593108 on ClinicalTrials.gov